Wockhardt Company Profile

✉ Email this page to a colleague

WOCKHARDT has seventy-six approved drugs.

There are seven US patents protecting WOCKHARDT drugs. There are three tentative approvals on WOCKHARDT drugs.

There are fifty-five patent family members on WOCKHARDT drugs in eighteen countries and one hundred and two supplementary protection certificates in seventeen countries.

International Patents:	55
US Patents:	7
Tradenames:	57
Ingredients:	54
NDAs:	76
Patent Litigation for Wockhardt:	See patent lawsuits for Wockhardt
PTAB Cases with Wockhardt as petitioner:	See PTAB cases with Wockhardt as petitioner

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wockhardt	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065197-002	Jun 20, 2008		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Wockhardt Bio Ag	ZAYNICH	cefepime hydrochloride; zidebactam	POWDER;INTRAVENOUS	220787-001	May 29, 2026		RX	Yes	Yes	9,132,133	⤷ Start Trial				⤷ Start Trial
Wockhardt	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	075586-001	May 30, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Wockhardt Ltd	CARBIDOPA, LEVODOPA AND ENTACAPONE	carbidopa; entacapone; levodopa	TABLET;ORAL	090833-001	Nov 20, 2012		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Wockhardt Bio Ag	FELODIPINE	felodipine	TABLET, EXTENDED RELEASE;ORAL	091484-002	Aug 15, 2012		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Wockhardt Ltd	CARBIDOPA, LEVODOPA AND ENTACAPONE	carbidopa; entacapone; levodopa	TABLET;ORAL	090833-004	Nov 20, 2012		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0443983	2007C/043	Belgium	⤷ Start Trial	PRODUCT NAME: AMLODIPINE ET VALSARTAN; NATL. REGISTRATION NO/DATE: EU/1/06/370/001 20070118; FIRST REGISTRATION: CH 57771 20061222
1534313	122015000111	Germany	⤷ Start Trial	PRODUCT NAME: PHENYLEPHRIN UND KETOROLAC; REGISTRATION NO/DATE: EU/1/15/1018 20150728
0503785	C300486	Netherlands	⤷ Start Trial	PRODUCT NAME: COMBINATIE VAN OLMESARTANMEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, AMLODIPINEBESYLAAT AND HYDROCHLOORTHIAZIDE; NATL REGISTRATION NO/DATE: RVG 106667, RVG 106671-74, RVG 106682-86 20101221; FIRST REGISTRATION: DE 79810.00.00-79814.00.00 20101216
1534313	2015/071	Ireland	⤷ Start Trial	PRODUCT NAME: AN OCULAR IRRIGATION SOLUTION COMPRISING PHENYLEPHRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND KETOROLAC OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1018 20150728
2236132	C300714	Netherlands	⤷ Start Trial	PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
1304992	132013902214376	Italy	⤷ Start Trial	PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.